Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Strategic Alliance

8 Dec 2005 08:23

Synexus Clinical Research PLC08 December 2005 Synexus Clinical Research plc ("Synexus") Forms Strategic Alliance with ICRI Research (P) Ltd. ("IRL") to establish India's first patient-recruitment Site Management Organisation (SMO) Synexus Clinical Research plc, the provider of clinical trials services to theglobal pharmaceutical industry, has entered into a strategic alliance with theIndian Clinical Research Institute, through the latter's Mumbai-based subsidiaryIRL. IRL-Synexus will establish a chain of fully owned GCP-compliant investigatorsites (IRL-Synexus Clinical Research Centres) across India, and the first hasnow been formally opened in Mumbai. All patients will be recruited throughinternationally accepted methods and the first patient is expected to berecruited to a trial in the first three months of 2006. Under the terms of the agreement, IRL's full-time GCP trained clinical researchteam are further trained by Synexus in UK, to ensure full implementation inIndia of Synexus' operating procedures. Synexus will continue to support andmonitor the centres in India to ensure compliance with these procedures. Synexus recently listed on AIM, with the declared strategy of replicating,through acquisitions and partnerships, its successful UK operations across arange of countries important to its clients for running clinical trials. TheIRL-Synexus alliance is the first of these strategic steps. Commenting on the collaboration, Dr Ian Smith, Medical Director of Synexus,said: "India possesses tremendous potential to become a preferred location forresearch and development for the global biotechnology and pharmaceutical sector.I am delighted that Synexus has formed an alliance with IRL, whose core valuesof expertise, proficiency and training blend perfectly with our systematic andeffective approach." Press enquiries Synexus Clinical Research plc Tel: +44 (0)1257 230 723Michael Redmond, Executive ChairmanDr Ian Smith, Medical Director Biddicks Tel: +44 (0)20 7448 1000Zoe Biddick NOTES TO EDITORS Synexus Clinical Research plc was formed in 1998 and is the largest patientrecruitment organisation in Europe. Synexus undertakes clinical trials servicesfor the global pharmaceutical industry, managing patients on clinical trials onbehalf of pharmaceutical companies and contract research organisations. Synexussources patient, assesses them for suitability through a screening process,manages the patients on the trials and collates data before reporting back toits client. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 20267:00 amRNSEBT Share Purchase
1st Jun 20261:48 pmRNSEBT Share Purchase
20th May 20267:00 amRNSFunding of EBT to Acquire Ordinary Shares and RPT
18th May 202612:48 pmRNSResult of AGM
18th May 20267:01 amRNSBoard Change
18th May 20267:00 amRNSAGM Trading Update
23rd Apr 20261:30 pmRNSCorrection to Notice of Annual General Meeting
14th Apr 20267:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
13th Mar 20262:05 pmRNSDirector dealings
12th Mar 20267:00 amRNSDirector Dealings
9th Mar 202610:20 amRNSDirector Dealings
3rd Mar 20263:30 pmRNSDirector / PCA Dealings
3rd Mar 20267:00 amRNSFinal Results and Strategic Update
24th Feb 202612:15 pmRNSNotice of Final Results and Investor Presentation
23rd Feb 20267:00 amRNSOngoing New Business Momentum
19th Feb 20261:41 pmRNSHolding(s) in Company
19th Jan 20269:00 amRNSHoldings in Company
18th Dec 202510:00 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSFull Year Trading Update
24th Nov 20257:00 amRNS-RExtension of Framework Agreement with Stagecoach
3rd Nov 20257:00 amRNS£1.8 million contract with Bus Eireann
16th Oct 20257:01 amRNSNew Contracts - Traction in Broader Energy Sector
16th Oct 20257:01 amRNSTrading Update
16th Oct 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
9th Oct 202512:16 pmRNSDirector dealings
2nd Oct 20257:00 amRNSPDMR dealings
2nd Sep 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSPDMR dealings
16th Jul 20257:00 amRNSLeisure & Hospitality Contract Wins
8th Jul 20257:00 amRNSHalf-year Report
19th Jun 20257:00 amRNSAppointment of Chief Financial Officer
9th Jun 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNSUS$4.8m Contract Extension
21st May 20257:00 amRNSPDMR Dealings
12th May 20257:00 amRNS£1.1 million Contract Award
7th May 20251:00 pmRNSResult of Annual General Meeting
7th May 20257:00 amRNSAGM Trading Update
2nd Apr 20257:00 amRNSPDMR dealings
1st Apr 20257:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
31st Mar 20257:00 amRNS£2.0 million Award
4th Mar 20257:00 amRNSFinal Results
14th Feb 20257:00 amRNSNotice of Final Results and Investor Presentation
27th Jan 20257:00 amRNS$2.2 million Contract Award
13th Jan 20255:30 pmRNSHoldings in Company
6th Jan 20258:40 amRNSHoldings in Company
6th Jan 20258:30 amRNSHoldings in Company
9th Dec 20241:30 pmRNSHoldings in Company
9th Dec 20247:00 amRNSTrading Update
5th Dec 20247:00 amRNS$2.7 million Contract Awards
27th Nov 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.